It is well known that morphine produces hyperglycemia in some laboratory animals such as rats, dogs and so on (1) by inducing the release of catecholamine from the adrenal medulla (2). As catecholamine raises the level of free fatty acids (FFA) in blood as well as that of glucose (3), there would be a possibility that morphine also raises the level of FFA in blood. On the other hand the changes of FFA in serum by the administration of morphine were reported scarcely (4, 5). The purpose of the present investigation was to examine the changes of the level of FFA in serum of the morphine-tolerant and non tolerant rats by the administration of or by the withdrawal from morphine, and was also to see whether the level of FFA in serum of the rats changed in parallel with that of glucose in blood when the rats were treated with morphine.
FFA in blood. On the other hand the changes of FFA in serum by the administration of morphine were reported scarcely (4, 5) . The purpose of the present investigation was to examine the changes of the level of FFA in serum of the morphine-tolerant and non tolerant rats by the administration of or by the withdrawal from morphine, and was also to see whether the level of FFA in serum of the rats changed in parallel with that of glucose in blood when the rats were treated with morphine.
In some cases, the content of FFA of the epididymal fat pad and the rate of lipolysis were examined in order to know the effect of morphine on the lipolysis of the adipose tis sue, which is supposed to change the level of FFA in serum.
MATERIALS AND METHODS
Drags: Morphine, N-allylnormorphine (nalorphine) and propranolol were used as the hydrochlorides dissolved in physiological saline solution. Ergotamine tartrate was dissolved by adding tartaric acid solution (final pH ca 2).
Animals: Male albino rats of the Donryu strain were used in all the experiments.
They were fed on a standard chow (type NMF, Oriental Kobo Co.) ad libitum with tap water. On the day of decapitation the chow was took away from them.
Morphine hydrochloride was administered to rats subcutaneously twice daily over 6 weeks repeatedly in order to make them dependent on morphine as follows: A single dose was 20 mg/kg of body weight at the beginning and was increased by 20 mg/kg every 5 days as high as 100 mg/kg. The rat receiving morphine hydrochloride 100 mg/kg twice daily for more than 10 days was considered to be tolerant to morphine.
The rat which was given 5 ml/kg of physiological saline solution for the same period was used as a control.
Animals were killed by decapitation, the blood was collected in a beaker and the re sulted serum was used for the assay of glucose and FFA. The epididymal fat pad was excised for the incubation. A slightly modified method of Stock and Westermann (3) as follows was used for the incubation: The epididymal fat pad weighing about 100 mg 1. FFA and glucose in serum One hour after the administration of 20 or 40 mg/kg of morphine hydrochloride for the first time, the level of glucose in blood elevated significantly, but the concentration of FFA in serum did not show any change (Table 1 ). The rat given 40 mg/kg showed even a lower value of FFA than the saline control.
After the successive 10 days' administration of morphine the value of glucose 1 hour after the administration of morphine hydrochloride (40 mg/kg) did not show an eleva tion, that can be regarded as a phenomenon of tolerance ( Table 2 ). The level of FFA showed a trend of increment on the other hand.
One hour after the administration of morphine hydrochloride (100 mg/kg) to the morphine-tolerant rat, a decrease of glucose and inversely an increase of FFA in serum were noticed in contrast to those of the saline control (Table 3) . Withdrawal of mor phine for 24 hours did not show any changes in the tolerant rat. When nalorphine was injected to the tolerant rat, the rat revealed typical withdrawal synlptomes and a high value of glucose with a slight incement of FFA in serum. Two hours after the administration of morphine or nalorphine to the tolerant rat, the changes of FFA or glucose showed almost the same trend as those 1 hour after the administration of these drugs (Table 4 ). Table 4 also shows that the normal rat received nalorphine for the first time revealed a slight but not significant increase of FFA in serum with no increment of the level of glucose in blood.
In order to know the contribution of the sympathetic nervous system to the high con centration of FFA in serum of the tolerant rat after the administration of morphine, the effect of the adrenergie blockade on the level of FFA was examined (Table 5 ). In the control rat, ergotamine tartrate (0.25 mg/kg intraperitoneally 15 minutes prior to the phys iological saline solution) or propranolol hydrochloride (10 mg/kg subcutaneously 30 minutes prior to the saline) showed no changes of FFA nor glucose in comparison to those without adrenergic blockade. In the tolerant rat a tendency to hypoglycemia was not altered by the adrenergic blockade. The pretreatment with ergotamine tartrate (0.25 mg/kg intraperitoneally 15 minutes prior to 100 mg/kg of morphine hydrochloride given sucutane ously) decreased the elevated level of FFA in serum of the tolerant rat due to the admin istration of morphine significantly. Propranolol hydrochloride (10 mg/kg subcutaneously 30 minutes prior to morphine) did not lower the level of FFA in serum significantly.
Epididymal fat pad
As FFA in serum is thought to be derived from the adipose tissue, the content of F FA and the rate of lipolysis in the epididymal fat pad were also examined ( Table 6 ). The difference of the content of FFA in the fat pad during the incubation (JFFA) and the amount of glycerol released into the medium were determined as a measure of the lipoly sis. The content of FFA in the epididymal fat pad excised from the tolerant rat 1 hour after the administration of morphine was higher than that of the saline control, that was in agreement with the elevated level of FFA in serum of the tolerant rat. Twenty-four hours' withdrawal or the treatment with nalorphine, which did not increase the level of FFA inserum, caused only a slight but not significant increase in the content of FFA in the adipose tissue of the tolerant rat in contrast to that of the saline control.
JFFA's of the fat pads from the saline control and the tolerant rat after 24 hours' withdrawal were negative, but those from the morphine and nalorphine-treated tolerant or the release of glycerol of the fat pad of the normal rat ( Table 7) . The content of FFA of the fat pad from the tolerant rat received adrenergic blocking agents showed a tendency to decrease though not significantly.
The release of glycerol from the fat pad was more in the tolerant rat than in the saline control. Adrenergic blocking agents given in vivo did not diminish this elevated release of glycerol significantly.
DISCUSSION
The rise of glucose in blood in some laboratory animals by the administration of mor phine is attributed to the release of the catecholamine from the adrenal medulla which is the result of the stimulation of the region near the formean of Monro (2). It was re ported (10, 11) also that morphine increased the urinary excretion of catecholamines in the rat, and this effect was subsequently reduced during the chronic morphine administra tion, but there occurred a rise in the urinary output of catecholamines again when the chronic morphine administration was abruptly withdrawn. It was noted in the present investigation that the initial administration of morphine produced hyperglycemia in the rat, but morphine did not raise the glucose in blood of the rat after the repeated adminis tration of morphine. Nalorphine-induced abstinence caused hyperglycemia in the mor phine-tolerant rat, though 24 hours' withdrawal could not raise the level of glucose in blood. The above noted changes of the level of glucose seem to coincide with the re ported changes of the urinary excretion of catecholamines and to be understood in rela tion to the catecholamine secreted from the adrenals.
The level of FFA in serum is regulated by many factors, one of which is the catechol amine. So it was expected that the level of FFA in serum increased by the administra tion of morphine to the nontolerant rat which would respond with the release of the cate cholamine from the adrenal medulla. Fresia (4) reported that the normal rats treated with 20 mg/kg of morphine hydrochloride showed the increased concentration of FFA in plas ma, and he concluded this elevated value of FFA was mainly due to the catecholamine from the adrenal medulla. In the present investigation, however, the result of Fresia was not reproduced. The normal level of FFA in the rat received morphine for the first time is rather difficult to interpret by the catecholamine alone and needs further investi gation about the contribution of the other factors, though the rise due to morphine might be covered by the wide range of fluctuation of the level of FFA in serum of the rat.
Morphine raised the level of FFA in serum of the morphine-tolerant rat markedly.
This trend was seen at the 11th day of the repeated administration of morphine, when the tolerance was built up in relation to the hyperglycemia due to morphine. This failure may he due to the premature development of the abstinence syndrome, not to the insufficient tolerance to morphine, because nalorphine precipitated a typical abstinence syndrome in these tolerant rats.
Nalorphine had no effect on the level of glucose in blood of the normal rat, but raised the level of FFA slightly but not significantly.
In the tolerant rat received nalorphine the rise of the level of FFA appeared later than the hyperglycemia and was less pronounced than in the tolerant rat received mor phine.
The failure of the increment of FFA in serum or of the lipolysis in the fat pad of the nalorphine-abstinent rat can not be understood simply by the release of catecholamine from the adrenals.
SUMMARY
The effect of morphine on the level of FFA in serum of the rat was investigated in relation to glucose in blood. The changes of glucose in blood by the administration of morphine can be understood mainly by the changes of the released catecholaminc from the adrenal medulla, but those of FFA in serum were rather complicated .
The rat received morphine for the first time showed no significant changes of the level of FFA in serum in contrast to hyperglycemia. When morphine was repeatedly adminis tered to a rat, the rat showed a tolerance to morphine in relation to the hyperglycemic effect of morphine. But this tolerant rat responded to the administration of morphine with the increase of the level of FFA in serum and the enhanced lipolysis in the adipose tissue. This high level of FFA in serum of morphine-administered tolerant rat was di minished by the pretreatment with ergotamine tartrate.
Nalorphine had no effect on the level of glucose in blood of the normal rat but show ed a tendency to raise the level of FFA in Serum.
When the morphine-tolerant rat was made abstinent by nalorphine, only a slight increase of the level of FFA in serum was noticed later than the occurrance of hyperglycemia, but the FFA content of the fat pad of the nalorphine-abstinent rat hardly increased.
Withdrawal of morphine from the tolerant rat for 24 hours did not change the level of FFA nor glucose in blood.
Neither morphine nor nalorphine had any effect on the lipolysis of the adipose tissue in vitro.
